Network origin in Alison O'Neill first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
The University of Alabama
28
| College/University | Other Consumer Services | 28 |
| Holding Company | Biotechnology | 24 | |
| Subsidiary | Biotechnology | 19 | |
TransMolecular, Inc.
 TransMolecular, Inc. BiotechnologyHealth Technology TransMolecular is an oncology-focused biotechnology company committed to developing novel proprietary drugs to diagnose and treat human diseases using a novel tumor targeting platform called TM601. Their development program to date has explored the therapeutic use of TM601 in cancer and neovascular diseases of the eye, and their lead candidate, TM601 conjugated to the radioactive isotope 131I, has a Special Protocol Agreement (SPA) with the FDA for a pivotal, Phase 3 trial in newly diagnosed glioblastoma multiforme (glioma). TM601 has unique properties of highly specific tumor cell binding and internalization while not affecting normal cells, targeting both primary disease sites and metastases. The interaction of TM601 with a specific protein known to be over-expressed on the surface of tumor cells and vascular endothelium is implicated in these tumor-specific binding properties. Conjugated to an anti-cancer radioactive isotope, TM601 has been successful in human and animal models in demonstrating selective targeting and uptake in a number of different tumor types, and in tumor locations within the central nervous system (CNS) and peripherally. Expanded research confirms that TM601 can deliver a variety of conjugates, creating potential for development of a wide array of anti-cancer therapies. In addition to the tumor targeting capability of TM601, a number of studies have also revealed that TM0601 exerts robust anti-angiogenic effects on vessels associated with neovascular disease. Pursuing this anti-angiogenic potential further, They have also determined the utility of TM601 in animal ophthalmic models. The company is leveraging its platform in strategic collaborations with partners seeking to expand product pipelines, extend product life-cycles for existing anti-tumor compounds, or optimize therapeutic activity of marginally effective or restrictively toxic drugs.
12
| Extinct | Biotechnology | 12 |
OptumInsight, Inc.
 OptumInsight, Inc. Information Technology ServicesTechnology Services OptumInsight, Inc. provides healthcare information technology and consulting services. It offers technology services, information, analytics, business services and consulting to help solve the most important problems clients face across the health system. The firm provides solutions for physicians, hospitals, life sciences companies, government agencies and other organizations that comprise the health care system. The company is headquartered in St. Paul, MN.
2
| Subsidiary | Information Technology Services | 2 |
Massachusetts General Hospital Cancer Center
 Massachusetts General Hospital Cancer Center Hospital/Nursing ManagementHealth Services Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA.
2
| Subsidiary | Hospital/Nursing Management | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Alison O'Neill via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree Director/Board Member Graduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Director/Board Member Graduate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| 2SEVENTY BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| The University of Chicago | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
Diacrin, Inc. (Delaware)
 Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Diacrin, Inc. develops human cell transplant therapeutic products. The company is headquartered in Wilmington, DE. | Medical Specialties | Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal | |
| GENVEC INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal President Founder | |
| ELOXX PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Chief Executive Officer Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BLUEBIRD BIO, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor Consultant / Advisor | |
| Harvard Business School | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| Auburn University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Michigan | College/University | Masters Business Admin Graduate Degree | |
| ZYLA LIFE SCIENCES | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Undergraduate Degree | |
| SHIRE | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| MIRATI THERAPEUTICS | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Director/Board Member | |
UAB Health Systems
 UAB Health Systems Hospital/Nursing ManagementHealth Services UAB Health Systems specializes in orthopaedics, which deals with injuries and diseases affecting the musculoskeletal system. The private company is based in Birmingham, AL and has subsidiaries in the United States. UAB is recognized as one of the top transplant centers in the country, with a history of achievement in organ transplantation. UAB Medicine is a top academic medical center and a leader in quality patient care, research, and training. UAB Women & Infants Services provides assistance with planned and unexpected health needs. | Hospital/Nursing Management | Chairman Corporate Officer/Principal | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| RUBIUS THERAPEUTICS | Biotechnology | Director of Finance/CFO Investor Relations Contact | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of Utah | College/University | Undergraduate Degree Doctorate Degree | |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
Cortado Capital LLC
 Cortado Capital LLC Investment ManagersFinance Cortado Capital LLC (Cortado Capital) is a venture capital firm founded by Nathaniel Harding, David Woods, and Mike Moradi in 2017. The firm is headquartered in Oklahoma. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| Manderson Graduate School of Business At University of Alabama | College/University | Masters Business Admin Masters Business Admin | |
| SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Undergraduate Degree | |
Renagade Therapeutics, Inc.
 Renagade Therapeutics, Inc. BiotechnologyHealth Technology Renagade Therapeutics, Inc. is an American US-based company that aims to overcome the limitations of RNA medicines by applying their comprehensive deliver, code, edit, insert technologies to precisely correct disease on an unprecedented scale. The company has developed a broad portfolio of RNA delivery systems, which profoundly expand the array of addressable diseases. The company's proprietary, synergistic toolkit allows them to precisely deliver, code, edit, and insert RNA medicines to treat any disease, anywhere in the body. Renagade is built on a foundation of proprietary delivery technologies to unlock previously inaccessible cells, reprogramming cells with superior expression using the leading RNA coding platform via joint venture with Orna Therapeutics, enabling curative therapies by permanently correcting defective genes with proprietary technology, and industry-leading all-RNA system to enable exon or large gene insertions as a gene therapy 2.0 platform. Renagade is backed by MPM BioImpact and F2 Ventures, leading financial groups who have supported the development of over 50 products to market. | Biotechnology | Founder Director of Finance/CFO | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | President Corporate Officer/Principal | |
Tullis Health Investors, Inc.
 Tullis Health Investors, Inc. Investment ManagersFinance Tullis Health Investor Inc (Tullis Health) is a private equity and venture capital firm founded in 1986 by Jim Tullis. The firm is headquartered in Palm Beach, Florida. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Compliance Officer |
Statistics
International
| United States | 47 |
| United Kingdom | 2 |
| Ireland | 2 |
| Germany | 2 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 15 |
| Finance | 5 |
| Commercial Services | 4 |
| Health Services | 4 |
Operational
| Director/Board Member | 264 |
| Corporate Officer/Principal | 182 |
| Undergraduate Degree | 79 |
| Independent Dir/Board Member | 72 |
| Chairman | 61 |
Most connected contacts
| Insiders | |
|---|---|
| Ansbert Gadicke | 56 |
| Daniel Lynch | 32 |
| Curt LaBelle | 32 |
| Hubert Birner | 27 |
| David Scadden | 26 |
| Dave Grayzel | 23 |
| Charles Sigal | 20 |
| Denice Torres | 19 |
| Wynetka Ann Reynolds | 18 |
| Robert Radie | 18 |
| J. Goater | 17 |
| Armen Shanafelt | 17 |
| Lyle A. Hohnke | 17 |
| Peter L. Slavin | 16 |
| Jonathan Lloyd Jones | 14 |
- Stock Market
- Insiders
- Alison O'Neill
- Company connections
